Mumbai: Pharma Major Cadila Healthcare said that USFDA inspected the injectables manufacturing facility of Liva Pharmaceuticals Ltd a 100 percent subsidiary of Cadila Healthcare Ltd located at Vadodara.
The inspection was made from August 20 to August 28, 2018, the company said in a filing with BSE.
This was a product-specific Pre Approval Inspection. The inspection concluded with 5 observations. Liva will respond to the USFDA within 15 days.
At present Liva does not export any products to the US market, the filing added.